$3.57
Today
as of Sep 4, 16:46 ET
Last 30 days
Recent Press Releases & News
BriaCell Shares Turn Volatile After Melanoma Vaccine Development Milestone
BriaCell Advances Personalized Melanoma Immunotherapy Vaccine Candidate, Bria-MEL+™
BriaCell Gets FDA Approval to Start Phase 1/2a of Prostate Cancer Immunotherapy Study
Overview
52-week range
$2.60
$15
8% of range
Avg surprise (last 1)
+6.8%
Avg reaction (last 1)
+1.3%
100% positive
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Thu Apr 30, 2026 | Apr 2026 | $-0.99 | — | — | — | — | financials |
| Sat Jan 31, 2026 | Jan 2026 | $-2.58 | — | — | — | — | financials |
| Fri Oct 31, 2025 | Oct 2025 | $-4.35 | — | — | — | — | financials |
| Mon Jun 16, 2025 | Apr/2025 | $-1.64 | $-1.76 | +6.8% | — | +1.3% | earnings |
| Wed Apr 30, 2025 | Apr 2025 | $-16.42 | — | — | — | — | financials |
| Fri Jan 31, 2025 | Jan 2025 | $-23.31 | — | — | — | — | financials |
| Thu Oct 31, 2024 | Oct 2024 | $-32.67 | — | — | — | — | financials |
| Tue Apr 30, 2024 | Apr 2024 | $1.61 | — | — | — | — | financials |
| Wed Jan 31, 2024 | Jan 2024 | $-10.64 | — | — | — | — | financials |
| Tue Oct 31, 2023 | Oct 2023 | $-0.50 | — | — | — | — | financials |
| Sun Apr 30, 2023 | Apr 2023 | $-0.32 | — | — | — | — | financials |
| Tue Jan 31, 2023 | Jan 2023 | $-0.77 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Apr 2026 | Jan 2026 | Oct 2025 | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-8M | $-8M | $-8M | — | $-6M | $-7M | $-5M | — |
| Net income | $-7M | $-7M | $-8M | — | $-6M | $-6M | $-6M | — |
| EPS (diluted) | $-0.99 | $-2.58 | $-4.35 | — | $-16.42 | $-23.31 | $-32.67 | — |
Balance sheet (quarterly)
| Metric | Apr 2026 | Jan 2026 | Oct 2025 | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $7M | $30M | $3M | $10M | $12M | $5M | $6M | $862,089 |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $25M | $32M | $11M | $20M | $15M | $7M | $8M | $4M |
| Total assets | $27M | $34M | $13M | $22M | $17M | $9M | $10M | $6M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | — | — | — | — | — | — | — | — |
| Total equity | $23M | $30M | $9M | $17M | $12M | $3M | $4M | — |
Implied volatility — last 90 days
No IV snapshots yet for BCTX.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.